Oregon Psilocybin Services Offer Lasting Benefits
A study from Oregon Health & Science University indicates that state-regulated psilocybin services provide lasting mental health benefits for participants suffering from anxiety and depression. The research confirms that safety outcomes in real-world settings mirror those observed in controlled clinical trials.
Why it matters
This study provides empirical evidence for the efficacy and safety of legalized psychedelic therapy, potentially influencing future public health policy.
People participating in an Oregon Health & Science University-led study of state-regulated psilocybin services reported relief from symptoms of anxiety, depression and post-traumatic stress disorder - with almost two-thirds declaring the experience to be among the most meaningful of their life.
The findings, published today in the journal JAMA Network Open, represent the first multisite study of the legalized psilocybin market approved by Oregon voters in 2020.
"Safety was very similar to what we've seen with psychedelics in clinical settings," said lead author Todd Korthuis, M.D., professor of medicine (general internal medicine and geriatrics) in the OHSU School of Medicine. "That's important because there was a big question around whether or not safety in carefully controlled psilocybin clinical trials would translate into real-world use."
Oregon voters approved a non-medical wellness model, making state-licensed access to mind-altering "magic mushrooms" available for people aged 21 and older starting in 2023 .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in